Citation: | LIU Xuantong. Efficacy and security of double dosage of clopidogrel in treatment of patients with clopidogrel resistance after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2014, (1): 30-32,52. DOI: 10.7619/jcmp.201401009 |
张力俨, 张翠丽, 富路. 急性心肌梗死经皮冠状动脉介入治疗研究进展 [J]. 心血管病学进展, 2011(1):64.
|
Burazeri G, GodaA, SuloG. Conventional risk factors and acute coronary syndrome during a period of socioeconomic transition:population-based case-control study in Tirana, Albania [J]. Croatian Medical Journal, 2007(2):225.
|
Bonello L, Tantry U S, Marcucci R. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate [J]. Journal of the America College of Cardiology, 2010, (12):919.
|
高润霖. 冠心病介入治疗的新进展:解读中国更新的经皮冠状动脉介入治疗指南 [J]. 中华心血管病杂志, 2009(1):2.
|
中华医学会心血管病学分会, 中华心血管病杂志编辑委员. 经皮冠状动脉介入治疗指南(2009) [J]. 中华心血管病杂志, 2009(1):4.
|
李靖, 王乐丰. 急性冠脉综合征抗栓治疗出血情况研究现状 [J]. 国际心血管病杂志, 2009(5):270.
|
罗芝宽, 刘勇, 李广阔. 抗血小板药物对冠心病患者介入术后无复流发生率的影响 [J]. 中华老年医学杂志, 2013(4):379.
|
王苏, 张京梅, 赵秀清. 冠状动脉介入术后氯吡格雷抵抗及影响因素 [J]. 中华实用诊断与治疗杂志, 2010(9):844.
|
郝盼盼, 陈玉国, 张运. 氯吡格雷抵抗相关因素的研究进展 [J]. 心血管病学进展, 2009(6):991.
|
任可, 宋耀明, 何作云. 冠心病患者冠状动脉介入治疗术后氯吡格雷抵抗的发生率及影响因素 [J]. 第三军医大学学报, 2011(5):535.
|
王嘉莉, 柯元南. 氯吡格雷抵抗的临床研究现状 [J]. 中日友好医院学报, 2007(1):44.
|
Gurbel P A, Bliden K P, Hiatt B L. Clopidogrel for coronary stenting:response variability, drug resistance, and the effect of pretreatment platelettre activity [J]. CIRCULATION, 2003, (23):2908.
|
Von Beckerath N, Taubert D, Pogatsa-Murray G. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel results of the ISAR-CHOICE (Imracoronary Stenting and Antithrombotic Regimen:Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial [J]. CIRCULATION, 2005, (19):2946.
|
Montalescot G, Sideris G, Meuleman C. A randomized comparison of high clopidogrel loading doses in patients with non-ST-elevation acute coronary syndromes:the ALBION trial [J]. Journal of the America College of Cardiology, 2006(5):931.
|
Bonello L, Camoin-Jau L, Arques S. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events inpatients with clopidogrel resistance [J]. Journal of the America College of Cardiology, 2008, (14):1404.
|